| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |